5-Bromo-2-methyl-4-(piperidin-1-yl)pyridine

Catalog No.: 
ACIIDN880
CAS No.: 
103971-18-2
Molecular Formula: 
C11H15BrN2
Molecular Weight: 
255.16
5-Bromo-2-methyl-4-(piperidin-1-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$448.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-methyl-4-(piperidin-1-yl)pyridine
IUPAC Name5-bromo-2-methyl-4-(piperidin-1-yl)pyridine
Molecular FormulaC11H15BrN2
Molecular Weight255.16
SMILESCC1=NC=C(Br)C(N2CCCCC2)=C1
InChI KeyZAIQFLZYGDWOEI-UHFFFAOYSA-N
Synonym5-BroMo-2-Methyl-4-(piperidin-1-yl)pyridine;Pyridine, 5-bromo-2-methyl-4-(1-piperidinyl)-
CAS No.103971-18-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIIDN880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTUMB295 route compound structure diagram
    ACTUMB2951003711-85-0In Stock
  4. Then
  5. ACIIDN880 route product structure diagram
    ACIIDN880103971-18-2
Inquiry

2. ACIIDN880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFCL270 route compound structure diagram
    ACUFCL270111-24-0In Stock
  2. Plus
  3. ACXFYW385 route compound structure diagram
    ACXFYW3851820684-03-4In Stock
  4. Then
  5. ACIIDN880 route product structure diagram
    ACIIDN880103971-18-2
Inquiry

3. ACIIDN880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIIDN880 route product structure diagram
    ACIIDN880103971-18-2
Inquiry

Comments (0)